CompletedPhase 2NCT04963231
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
Studying Genetic obesity
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Principal Investigator
- David Meeker, MDRhythm Pharmaceuticals, Inc.
- Intervention
- Setmelanotide(drug)
- Enrollment
- 164 target
- Eligibility
- 6-65 years · All sexes
- Timeline
- 2021 – 2024
Study locations (30)
- HonorHealth Bariatric Center, Scottsdale, Arizona, United States
- InQuest Medical Reseacrh, Suwanee, Georgia, United States
- UMass Memorial Medical Center, Worcester, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Metro Detroit Endocrinology Center, Dearborn, Michigan, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Mississippi Center for Advanced Medicine, Madison, Mississippi, United States
- Mount Sinai, New York, New York, United States
- Columbia University, New York, New York, United States
- Ten's Medical Center - Pediatric Endocrinology Clinic, Staten Island, New York, United States
- University of North Carolina, Chapel Hill, North Carolina, United States
- Geisinger Clinic, Danville, Pennsylvania, United States
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Texas Tech, Amarillo, Texas, United States
- Endocrine Associates of Dallas and Plano, Dallas, Texas, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04963231 on ClinicalTrials.govOther trials for Genetic obesity
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07296900International Genetic Obesity RegistryUniversity of Ulm
- RECRUITINGNANCT06978504Impact of Genetic Polymorphisms And DASH Diet On Weight Loss Progression In Climacteric Women With Metabolic SyndromeNutrindo Ideais Research Center
- RECRUITINGNCT06694012Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2Osaka Metropolitan University
- RECRUITINGNANCT06380426Real-life Evaluation of WEGOVY (Semaglutide) Treatment in Adults With Monogenic Obesity (ObGeSema)Assistance Publique - Hôpitaux de Paris
- RECRUITINGNANCT06534541Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early LifeTrustees of Dartmouth College
- RECRUITINGNANCT05963971A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk FactorsColumbia University
- ACTIVE NOT RECRUITINGNCT06618430Evaluation Of DNA Methylation Pattern In Healthy, Sarcopenic, Obese And Sarcopenic Obese Older Women: A Cross-Sectional StudyUniversity of Sao Paulo
- RECRUITINGPHASE4NCT05919797Weight Loss Study: Genetics and Response to Naltrexone/BupropionColumbia University